Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001398344-25-019099·NOVAVAX INC
Schedule 13D ownership disclosure
Novavax Inc
Common Stock, Par Value $0.01 per share · CUSIP: 670002401
Event date: 2025-10-13
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Shah Capital ManagementReported CIK 0001383838
Shares: 11,742,523.00 · Class: 7.2%
- Shah Capital Opportunity Fund LPReported CIK 0001392302
Shares: 11,000,000.00 · Class: 6.8%
- Himanshu H. ShahReported CIK 0001738336
Shares: 11,811,780.00 · Class: 7.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001398344-25-019099
- Form type
- SCHEDULE 13D/A
- Filer
- NOVAVAX INC
- CIK
- CIK 1000694
- Filed
- Oct 14, 2025
- Reporting period
- Oct 13, 2025
- Description
- Schedule 13D beneficial ownership